| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Nurix Therapeutics, Inc. (NRIX) have been net sellers, shedding 49,260 shares worth roughly $1.2M on balance. In the past 30 days, 0 insiders bought and 4 sold.
All 4 insiders who sold still hold shares after their sales.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 123.5K | $3.19M | -6,861 | |
| CFO | 47.5K | $1.23M | -2,834 | |
| Other | 15.3K | $395.9K | -3,957 | |
| Dir | 10.8K | $277.6K | -22,583 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 31, 2022 | Gwenn Hansen70 | Chief Scientific Officer | Sale+OE | 1,165 | $12.88 | $15,005.78 | -5.2% | -6.8% | -56.1% | |
| Oct 31, 2022 | Christine Ring75 | General Counsel | Sale+OE | 699 | $12.88 | $9,003.47 | -10.2% | -6.8% | -56.1% | |
| Oct 31, 2022 | Hans van Houte56 | Chief Financial Officer | Sale+OE | 739 | $12.88 | $9,518.69 | -1.0% | -6.8% | -56.1% | |
| Aug 1, 2022 | Gwenn Hansen70 | Chief Scientific Officer | Sale+OE | 1,186 | $15.67 | $18,584.62 | -5.8% | -17.4% | -38.4% | |
| Aug 1, 2022 | Hans van Houte56 | Chief Financial Officer | Sale+OE | 752 | $15.67 | $11,783.84 | -1.0% | -17.4% | -38.4% | |
| Aug 1, 2022 | Stefani Wolff65 | EVP and COO | Sale+OE | 356 | $15.67 | $5,578.52 | -22.3% | -17.4% | -38.4% | |
| Aug 1, 2022 | Christine Ring75 | General Counsel | Sale+OE | 712 | $15.67 | $11,157.04 | -13.4% | -17.4% | -38.4% | |
| May 2, 2022 | Christine Ring75 | General Counsel | Sale+OE | 660 | $11.75 | $7,755.00 | -16.2% | +28.8% | -21.4% | |
| May 2, 2022 | Hans van Houte56 | Chief Financial Officer | Sale+OE | 697 | $11.75 | $8,189.75 | -24.2% | +28.8% | -21.4% | |
| May 2, 2022 | Stefani Wolff65 | EVP and COO | Sale+OE | 330 | $11.75 | $3,877.50 | -34.3% | +28.8% | -21.4% |